Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3 -ITD mutations: results of the SAL MIDOKIT trial Leo Ruhnke , Christoph Roellig , Sylvia Herold , Tim Sauer , Christian H. Brandts , Bjoern Steffen , Kerstin Schaefer-Eckart , Stefan W. Krause , Mathias Haenel , Albrecht Reichle , Sebastian Scholl , Andreas Neubauer , Jan-Henrik Mikesch , Johannes Schetelig , Friedrich Stoelzel , Michael Kramer , Annett Haake , Julia Frimmel , Alwin Kraemer , Richard Schlenk , Uwe Platzbecker , Hubert Serve , Claudia D. Baldus , Carsten Mueller-Tidow , Daniela Aust , Martin Bornhaeuser , Gerhard Ehninger , Christian Thiede Haematologica（2023）
关键词
acute myeloid leukemia, intensive chemotherapy, sal midokit trial
AI 理解论文
溯源树
样例
